Cytokinetics (NASDAQ:CYTK) reported its Q1 earnings results on Thursday, May 4, 2023 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Cytokinetics missed estimated earnings by 15.0%, reporting an EPS of $-1.38 versus an estimate of $-1.2.
Revenue was up $3.46 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.24 which was followed by a 8.14% drop in the share price the next day.
Here’s a look at Cytokinetics’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -1.21 | -1.17 | -1.02 | -0.94 |
| EPS Actual | -1.45 | -1.52 | -0.23 | -1.02 |
| Revenue Estimate | 7.10M | 2.96M | 3.63M | 4.83M |
| Revenue Actual | 1.96M | 2.52M | 88.97M | 1.15M |
To track all earnings releases for Cytokinetics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
